The Bracco Group is a world leading provider of global diagnostic imaging
solutions, with net sales of about $1.25 billion. Bracco has operations in
115 countries and about 3,300 employees, around 600 of whom work in R&D.
Bracco invests approximately 15% of its annual turnover in R&D and has a
portfolio of 1,500 patents worldwide.
Bracco markets key diagnostic
imaging resources through the following companies: Esaote, which is one of
the world's primary producers of magnetic resonance and ultrasound imaging
systems; ACIST Medical Systems, a manufacturer of advanced contrast media
injection systems; EBIT-AET, which creates and markets medical application
software, and Singapore-based Volume Interactions, which also produces
advanced medical software.
Bracco also operates a high-level international research network, with
three centers (Milan, Geneva, and Princeton). These centers develop products
of the latest-generation diagnostic techniques, from X-ray and computed
tomography (CT) to magnetic resonance imaging (MRI) and echocontrast.